Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2010-2-22
pubmed:abstractText
It has recently been reported that tumor necrosis factor (TNF)-alpha has the ability to accelerate osteoclastogenesis. We previously reported that the proinflammatory cytokine interleukin (IL)-18 inhibits TNF-alpha-mediated osteoclastogenesis in mouse bone marrow cultures. In the present study, the effect of IL-18 on TNF-alpha-mediated osteoclastogenesis was investigated in vivo. We administered TNF-alpha with or without IL-18 into the supracalvaria of mice. The number of osteoclasts in the suture of the calvaria was increased in mice administered TNF-alpha. The number of osteoclasts in mice administered both TNF-alpha and IL-18 was lower than that in mice administered TNF-alpha alone. We previously showed that IL-12 and IL-18 synergistically inhibit TNF-alpha-mediated osteoclastogenesis in vitro. To assess the ability of these two cytokines to synergistically inhibit TNF-alpha-induced osteoclastogenesis in vivo, mice were administered the two cytokines at doses that did not inhibit osteoclast formation. The combination of IL-12 and IL-18 markedly inhibited TNF-alpha-induced osteoclastogenesis in vivo. To evaluate how IL-12 and IL-18 synergistically affect TNF-alpha-induced osteoclastogenesis, the IL-18 receptor (IL-18R) and IL-12R expression levels were analyzed by RT-PCR in bone marrow cells cultured with IL-12 or IL-18. IL-18R mRNA was increased in cells cultured with IL-12, while IL-12R mRNA was increased in cells cultured with IL-18. In addition, IL-18 inhibited TNF-alpha-induced osteoclastogenesis in mice with T-cell depletion caused by anti-CD4 and anti-CD8 antibodies. The present results suggest that IL-18 may inhibit TNF-alpha-mediated osteoclastogenesis in vivo via a T cell-independent mechanism.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1432-0827
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
86
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
242-8
pubmed:meshHeading
pubmed-meshheading:20111957-Animals, pubmed-meshheading:20111957-Bone Remodeling, pubmed-meshheading:20111957-Bone Resorption, pubmed-meshheading:20111957-Cell Count, pubmed-meshheading:20111957-Cell Differentiation, pubmed-meshheading:20111957-Cell Proliferation, pubmed-meshheading:20111957-Cells, Cultured, pubmed-meshheading:20111957-Dose-Response Relationship, Drug, pubmed-meshheading:20111957-Drug Synergism, pubmed-meshheading:20111957-Interleukin-12, pubmed-meshheading:20111957-Interleukin-18, pubmed-meshheading:20111957-Male, pubmed-meshheading:20111957-Mice, pubmed-meshheading:20111957-Mice, Inbred C57BL, pubmed-meshheading:20111957-Osteoclasts, pubmed-meshheading:20111957-RNA, Messenger, pubmed-meshheading:20111957-Receptors, Interleukin-12, pubmed-meshheading:20111957-Receptors, Interleukin-18, pubmed-meshheading:20111957-Stem Cells, pubmed-meshheading:20111957-T-Lymphocytes, pubmed-meshheading:20111957-Tumor Necrosis Factor-alpha, pubmed-meshheading:20111957-Up-Regulation
pubmed:year
2010
pubmed:articleTitle
IL-18 inhibits TNF-alpha-induced osteoclastogenesis possibly via a T cell-independent mechanism in synergy with IL-12 in vivo.
pubmed:affiliation
Department of Orthodontics and Dentofacial Orthopedics, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't